Skip to main content
. 2022 Jan 12;96(1):e01253-21. doi: 10.1128/JVI.01253-21

TABLE 1.

Compounds with SARS-CoV-2 Mpro activity identified in the initial screen

graphic file with name jvi.01253-21_t001.jpg